Stockreport

Guggenheim Sees Compass (CMPX) Potential Driven by Biliary Tract Cancer Pipeline [Yahoo! Finance]

Compass Therapeutics, Inc.  (CMPX) 
PDF now . The company's lead program, CTX-009, is progressing through clinical trials for advanced solid tumors, particularly biliary tract cancer (BTC), where the company e [Read more]